During early
urinary tract infection (UTI) the interplay between invading bacteria and the urothelium elicits a mucosal response aimed at clearing
infection. Unfortunately, the resultant
inflammation and associated local tissue injury are responsible for patient symptoms.
Interleukin-6 (IL-6), a
cytokine released during acute UTI, has both pro- and anti-inflammatory effects on other body systems. Within the urothelium, the
IL-6 native-tissue origin, the target cell type(s), and ultimate effect of the
cytokine on target cells are largely unknown. In the present study we modeled the UTI
IL-6 response ex vivo using canine bladder mucosa mounted in Ussing chambers to determine the inflammatory and reparative role of
IL-6. We demonstrated that uropathogenic Escherichia coli
infection stimulates the synthesis of
IL-6 by all urothelial cell layers, with the urothelial cells alone representing the only site of unequivocal
IL-6 receptor expression. Autocrine effects of
IL-6 were supported by the activation of urothelial STAT3 signaling and SOCS3 expression. Using exogenous
IL-6, a microarray approach, and quantitative
reverse transcriptase PCR (q-RT-PCR), 5 target genes (
tumor necrosis factor alpha,
interleukin-1β, matrix
metallopeptidase 2,
heparan sulfate d-glucosaminyl 3-O-
sulfotransferase 3A1, and
hyaluronan synthase 2) that have direct or indirect roles in promoting a proinflammatory state were identified. Two of these genes,
heparan sulfate d-glucosaminyl 3-O-sulfotransferase 3A1 and
hyaluronan synthase 2, are also potentially important mediators of
wound repair via the production of
glycosaminoglycan components. These findings suggest that
IL-6 secretion during acute UTI may serve a dual
biological role by initiating the inflammatory response while also repairing urothelial defenses.